Extendicare Financials

EXE Stock  CAD 24.55  0.07  0.28%   
Financial data analysis helps to check if markets are presently mispricing Extendicare. We were able to analyze and collect data for thirty-eight available fundamental indicators for Extendicare, which can be compared to its peers. The stock experiences a normal downward trend and little activity. Check odds of Extendicare to be traded at C$24.3 in 90 days.
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes

Extendicare Balance Sheet Chart

At this time, Extendicare's Total Liabilities is very stable compared to the past year. As of the 21st of February 2026, Property Plant And Equipment Gross is likely to grow to about 640.6 M, while Short and Long Term Debt Total is likely to drop about 250.1 M.
Key indicators impacting Extendicare's financial strength include:
Current ValueLast YearChange From Last Year 10 Year Trend
Operating Income90.1 M100.1 M
Moderately Down
Pretty Stable
Current Ratio1.030.96
Notably Up
Very volatile
  
Understanding current and past Extendicare Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Extendicare's financial statements are interrelated, with each one affecting the others. For example, an increase in Extendicare's assets may result in an increase in income on the income statement.

Extendicare Stock Summary

Extendicare competes with WELL Health, Sienna Senior, Cronos, Medical Facilities, and Nova Leap. Extendicare Inc. provides care and services for seniors in Canada. Extendicare Inc. was founded in 1968 and is based in Markham, Canada. EXTENDICARE INC operates under Medical Care Facilities classification in Canada and is traded on Toronto Stock Exchange. It employs 22800 people.
Foreign Associate
  USA
Specialization
Health Care, Health Care Equipment & Services
InstrumentCanada Stock View All
ExchangeToronto Exchange
ISINCA30224T8639
Business Address3000 Steeles Avenue
SectorHealth Care Providers & Services
IndustryHealth Care
BenchmarkDow Jones Industrial
Websitewww.extendicare.com
Phone905 470 4000
CurrencyCAD - Canadian Dollar
You should never invest in Extendicare without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Extendicare Stock, because this is throwing your money away. Analyzing the key information contained in Extendicare's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.

Extendicare Key Financial Ratios

Extendicare's financial ratios allow both analysts and investors to convert raw data from Extendicare's financial statements into concise, actionable information that can be used to evaluate the performance of Extendicare over time and compare it to other companies across industries.

Extendicare Key Balance Sheet Accounts

202120222023202420252026 (projected)
Total Assets900.3M781.6M672.7M719.8M647.8M1.1B
Other Current Liab4.4M13.8M7.9M6.2M5.6M5.3M
Net Debt432.2M216.7M259.3M170.6M153.6M145.9M
Accounts Payable193.0M250.1M197.1M241.5M277.7M148.0M
Net Receivables83.5M64.1M91.0M92.3M83.1M127.4M
Other Current Assets36.8M26.7M20.2M29.5M34.0M32.3M
Total Liab798.4M680.9M584.8M595.4M535.9M989.0M
Total Current Assets224.9M258.0M187.1M243.7M219.3M272.9M
Short Term Debt73.6M19.2M19.9M31.1M35.8M34.0M
Other Assets47.3M37.8M1.035.2M31.7M30.1M
Intangible Assets46.6M51.2M78.5M75.1M86.3M90.6M
Retained Earnings(402.5M)(384.6M)(393.5M)(352.5M)(317.3M)(333.2M)
Cash104.6M167.3M75.2M121.8M140.1M104.8M
Common Stock500.9M475.4M467.3M469.3M539.7M532.6M
Other Liab74.3M59.6M52.5M41.2M37.0M35.2M
Net Tangible Assets25.5M40.0M9.4M3.6M4.2M4.0M
Long Term Debt463.3M364.7M314.6M261.4M235.3M360.1M
Short Long Term Debt73.6M19.2M19.9M31.1M28.0M26.6M
Long Term Debt Total463.3M364.7M314.6M261.4M235.3M330.2M
Capital Surpluse8.2M10.6M13.1M14.3M16.5M17.3M

Extendicare Key Income Statement Accounts

202120222023202420252026 (projected)
Interest Expense22.4M21.7M21.6M21.1M24.3M43.0M
Total Revenue1.2B1.2B1.3B1.5B1.3B1.2B
Gross Profit115.6M76.8M167.6M168.0M151.2M143.6M
Operating Income49.7M21.0M63.0M111.2M100.1M90.1M
Ebit36.4M17.2M66.4M121.9M109.7M86.2M
Ebitda67.5M48.9M98.6M155.3M139.7M131.2M
Income Before Tax14.0M(4.5M)44.8M99.9M114.8M120.6M
Net Income11.5M69.6M34.0M75.2M86.5M90.8M
Income Tax Expense6.5M15K10.8M24.7M22.2M23.3M
Cost Of Revenue1.1B1.1B1.1B1.3B1.2B1.0B
Tax Provision7.0M15K10.8M24.7M28.3M29.8M
Interest Income23.7M15.5M6.2M13.1M11.8M15.0M
Net Interest Income(25.0M)(15.3M)(15.5M)(15.7M)(18.1M)(19.0M)

Extendicare Key Cash Accounts

202120222023202420252026 (projected)
Change In Cash(75.3M)62.7M(92.1M)46.7M42.0M44.1M
Free Cash Flow(6.1M)(2.8M)(106.1M)101.7M91.5M96.1M
Depreciation38.6M32.1M32.6M33.3M30.0M43.3M
Other Non Cash Items(10.6M)(59.5M)(10.3M)(13.5M)(12.2M)(11.5M)
Capital Expenditures65.2M101.6M129.4M42.0M37.8M50.8M
Net Income11.5M69.6M34.0M75.2M86.5M90.8M
End Period Cash Flow104.6M167.3M75.2M121.8M140.1M100.8M
Dividends Paid(43.0M)(42.6M)(40.4M)(40.0M)(36.0M)(34.2M)
Net Borrowings(30.0M)(114.2M)18.7M(44.5M)(40.1M)(38.1M)
Change To Netincome(19.3M)6.2M(283K)(57.0M)(51.3M)(48.8M)
Investments(63.7M)155.6M(84.5M)(9.1M)(10.5M)(11.0M)

Extendicare Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Extendicare's current stock value. Our valuation model uses many indicators to compare Extendicare value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Extendicare competition to find correlations between indicators driving Extendicare's intrinsic value. More Info.
Extendicare is one of the top stocks in return on equity category among its peers. It is rated # 2 in return on asset category among its peers reporting about  0.16  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Extendicare is roughly  6.30 . At this time, Extendicare's Return On Equity is very stable compared to the past year. Comparative valuation analysis is a catch-all model that can be used if you cannot value Extendicare by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Extendicare's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

Extendicare Total Assets Over Time

Most indicators from Extendicare's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Extendicare current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Extendicare. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in inflation.
As of the 21st of February 2026, Selling General Administrative is likely to grow to about 1.4 B. Also, Discontinued Operations is likely to grow to about 89.4 M
 2023 2024 2025 2026 (projected)
Gross Profit167.6M168.0M151.2M143.6M
Total Revenue1.3B1.5B1.3B1.2B

Extendicare fundamental ratios Correlations

0.810.560.580.280.80.570.85-0.480.820.260.750.56-0.420.840.440.620.960.680.580.390.19-0.820.24-0.57-0.56
0.810.170.160.180.980.440.99-0.580.950.240.820.52-0.440.99-0.020.550.80.850.120.720.1-0.810.17-0.37-0.35
0.560.170.98-0.320.060.580.22-0.390.08-0.05-0.03-0.240.090.240.97-0.010.68-0.080.970.020.42-0.54-0.41-0.56-0.56
0.580.160.98-0.230.070.560.21-0.280.08-0.110.02-0.15-0.010.210.970.10.67-0.030.990.010.29-0.51-0.32-0.52-0.52
0.280.18-0.32-0.230.33-0.180.210.480.440.460.460.91-0.440.15-0.230.710.010.33-0.17-0.24-0.23-0.130.98-0.02-0.03
0.80.980.060.070.330.350.98-0.450.980.260.890.65-0.490.96-0.110.660.740.910.040.660.0-0.750.33-0.33-0.31
0.570.440.580.56-0.180.350.43-0.430.340.080.280.01-0.190.480.52-0.030.650.260.560.270.23-0.52-0.26-0.31-0.32
0.850.990.220.210.210.980.43-0.580.960.260.830.54-0.450.980.030.610.820.850.170.70.11-0.810.2-0.46-0.44
-0.48-0.58-0.39-0.280.48-0.45-0.43-0.58-0.41-0.16-0.210.20.0-0.62-0.190.11-0.63-0.25-0.22-0.66-0.570.560.490.480.47
0.820.950.080.080.440.980.340.96-0.410.410.880.72-0.490.95-0.080.710.730.860.060.560.1-0.760.44-0.38-0.36
0.260.24-0.05-0.110.460.260.080.26-0.160.410.110.38-0.070.31-0.040.290.140.02-0.07-0.040.61-0.360.44-0.22-0.23
0.750.82-0.030.020.460.890.280.83-0.210.880.110.78-0.590.8-0.170.750.650.950.00.46-0.3-0.450.5-0.31-0.29
0.560.52-0.24-0.150.910.650.010.540.20.720.380.78-0.610.49-0.240.840.320.67-0.120.07-0.29-0.320.9-0.16-0.16
-0.42-0.440.09-0.01-0.44-0.49-0.19-0.450.0-0.49-0.07-0.59-0.61-0.380.12-0.64-0.31-0.530.01-0.290.370.31-0.380.110.09
0.840.990.240.210.150.960.480.98-0.620.950.310.80.49-0.380.040.520.840.820.190.640.21-0.820.15-0.41-0.39
0.44-0.020.970.97-0.23-0.110.520.03-0.19-0.08-0.04-0.17-0.240.120.04-0.060.52-0.240.98-0.180.37-0.42-0.33-0.48-0.49
0.620.55-0.010.10.710.66-0.030.610.110.710.290.750.84-0.640.52-0.060.440.660.070.26-0.21-0.410.73-0.27-0.25
0.960.80.680.670.010.740.650.82-0.630.730.140.650.32-0.310.840.520.440.620.650.470.27-0.81-0.03-0.59-0.58
0.680.85-0.08-0.030.330.910.260.85-0.250.860.020.950.67-0.530.82-0.240.660.62-0.070.54-0.31-0.480.36-0.24-0.22
0.580.120.970.99-0.170.040.560.17-0.220.06-0.070.0-0.120.010.190.980.070.65-0.07-0.090.3-0.5-0.27-0.47-0.48
0.390.720.020.01-0.240.660.270.7-0.660.56-0.040.460.07-0.290.64-0.180.260.470.54-0.090.07-0.5-0.21-0.21-0.17
0.190.10.420.29-0.230.00.230.11-0.570.10.61-0.3-0.290.370.210.37-0.210.27-0.310.30.07-0.43-0.26-0.31-0.31
-0.82-0.81-0.54-0.51-0.13-0.75-0.52-0.810.56-0.76-0.36-0.45-0.320.31-0.82-0.42-0.41-0.81-0.48-0.5-0.5-0.43-0.040.440.43
0.240.17-0.41-0.320.980.33-0.260.20.490.440.440.50.9-0.380.15-0.330.73-0.030.36-0.27-0.21-0.26-0.040.030.02
-0.57-0.37-0.56-0.52-0.02-0.33-0.31-0.460.48-0.38-0.22-0.31-0.160.11-0.41-0.48-0.27-0.59-0.24-0.47-0.21-0.310.440.031.0
-0.56-0.35-0.56-0.52-0.03-0.31-0.32-0.440.47-0.36-0.23-0.29-0.160.09-0.39-0.49-0.25-0.58-0.22-0.48-0.17-0.310.430.021.0
Click cells to compare fundamentals

Extendicare Account Relationship Matchups

Extendicare fundamental ratios Accounts

202120222023202420252026 (projected)
Total Assets900.3M781.6M672.7M719.8M647.8M1.1B
Other Current Liab4.4M13.8M7.9M6.2M5.6M5.3M
Net Debt432.2M216.7M259.3M170.6M153.6M145.9M
Accounts Payable193.0M250.1M197.1M241.5M277.7M148.0M
Net Receivables83.5M64.1M91.0M92.3M83.1M127.4M
Other Current Assets36.8M26.7M20.2M29.5M34.0M32.3M
Total Liab798.4M680.9M584.8M595.4M535.9M989.0M
Total Current Assets224.9M258.0M187.1M243.7M219.3M272.9M
Short Term Debt73.6M19.2M19.9M31.1M35.8M34.0M
Other Assets47.3M37.8M1.035.2M31.7M30.1M
Intangible Assets46.6M51.2M78.5M75.1M86.3M90.6M
Retained Earnings(402.5M)(384.6M)(393.5M)(352.5M)(317.3M)(333.2M)
Cash104.6M167.3M75.2M121.8M140.1M104.8M
Common Stock500.9M475.4M467.3M469.3M539.7M532.6M
Other Liab74.3M59.6M52.5M41.2M37.0M35.2M
Net Tangible Assets25.5M40.0M9.4M3.6M4.2M4.0M
Long Term Debt463.3M364.7M314.6M261.4M235.3M360.1M
Short Long Term Debt73.6M19.2M19.9M31.1M28.0M26.6M
Long Term Debt Total463.3M364.7M314.6M261.4M235.3M330.2M
Capital Surpluse8.2M10.6M13.1M14.3M16.5M17.3M
Today, most investors in Extendicare Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Extendicare's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Extendicare growth as a starting point in their analysis.

Price Earnings To Growth Ratio

0.1

At this time, Extendicare's Price Earnings To Growth Ratio is very stable compared to the past year.

Extendicare February 21, 2026 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Extendicare help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Extendicare. We use our internally-developed statistical techniques to arrive at the intrinsic value of Extendicare based on widely used predictive technical indicators. In general, we focus on analyzing Extendicare Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Extendicare's daily price indicators and compare them against related drivers.

Other Information on Investing in Extendicare Stock

Extendicare financial ratios help investors to determine whether Extendicare Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Extendicare with respect to the benefits of owning Extendicare security.